BioAmber (BIOA) Tops Q3 EPS by 14c

BioAmber (NYSE: BIOA) reported Q3 EPS of ($0.27), $0.14 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $2.3 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Worthington Enterprises raises dividend 5%, adds board member
• BofA lists top 5 themes driving next $1tn in incremental semi sales